Georges Gemayel Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

SUPN Quotes by TradingView

Georges Gemayel is Director of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 13,315 shares of SUPN, which is worth approximately $427,810. The most recent transaction as insider was on Sep 13, 2024, when has been sold 13,886 shares (Common Stock) at a price of $31.33 per share, resulting in proceeds of $435,048. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3K
22.59% 3M change
0% 12M change
Total Value Held $427,810

GEORGES GEMAYEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
SELL
Open market or private sale
$435,048 $31.33 p/Share
13,886 Reduced 51.05%
13,315 Common Stock
Sep 13 2024
BUY
Exercise of conversion of derivative security
$114,600 $11.46 p/Share
10,000 Added 30.02%
23,315 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
3,886 Added 18.43%
17,201 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
3,882 Added 22.57%
13,315 Common Stock
Feb 19 2022
BUY
Grant, award, or other acquisition
-
4,222 Added 30.92%
9,433 Common Stock

Also insider at

GMTX
Gemini Therapeutics, Inc. Healthcare
GG

Georges Gemayel

Director
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SUPN